The efficacy of istradefylline for treating mild wearing-off in Parkinson's disease
Clinical Neuropharmacology Nov 19, 2017
Ichiro Y, et al. - The efficacy of 20 mg/d istradefylline was evaluated in Parkinson's disease (PD) subjects experiencing an average daily OFF time of 3 hours or less. A significant improvement was observed with 20 mg/d istradefylline in motor functions among PD patients with mild wearing-off.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
